C22H26ClN7O3S
Neat
504.01
910297-57-3; 4'-Hydroxy Dasatinib; BMS-748730; Dasatinib metabolite M20; UNII-7EW75J44EY; 5-Thiazolecarboxamide, N-(2-chloro-4-hydroxy-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-; 7EW75J44EY; N-(2-Chloro-4-hydroxy-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-Chloro-4-hydroxy-6-methyl-phenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methyl-pyrimidin-4-yl)amino)thiazole-5-carboxamide; orb1986367; SCHEMBL1704509; DTXSID30474432; AKOS027321360; N-(2-Chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4; N-(2-chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1, 3-thiazole-5-carboxamide; DB-277149; HY-111158; CS-0034462; Q27268174; N-(2-CHLORO-4-HYDROXY-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-2-METHYL-4-PYRIMIDINYL}AMINO)-1 and 3-THIAZOLE-5-CARBOXAMIDE
N-(2-chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1 and 3-thiazole-5-carboxamide
InChI=1S/C22H26ClN7O3S/c1-13-9-15(32)10-16(23)20(13)28-21(33)17-12-24-22(34-17)27-18-11-19(26-14(2)25-18)30-5-3-29(4-6-30)7-8-31/h9-12,31-32H,3-8H2,1-2H3,(H,28,33)(H,24,25,26,27)